1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Tumor Biopsy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 ctDNA
1.2.3 CTC
1.3 Market by Application
1.3.1 Global Liquid Tumor Biopsy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinical Laboratories
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Liquid Tumor Biopsy Market Perspective (2017-2028)
2.2 Liquid Tumor Biopsy Growth Trends by Region
2.2.1 Liquid Tumor Biopsy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Liquid Tumor Biopsy Historic Market Size by Region (2017-2022)
2.2.3 Liquid Tumor Biopsy Forecasted Market Size by Region (2023-2028)
2.3 Liquid Tumor Biopsy Market Dynamics
2.3.1 Liquid Tumor Biopsy Industry Trends
2.3.2 Liquid Tumor Biopsy Market Drivers
2.3.3 Liquid Tumor Biopsy Market Challenges
2.3.4 Liquid Tumor Biopsy Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Liquid Tumor Biopsy Players by Revenue
3.1.1 Global Top Liquid Tumor Biopsy Players by Revenue (2017-2022)
3.1.2 Global Liquid Tumor Biopsy Revenue Market Share by Players (2017-2022)
3.2 Global Liquid Tumor Biopsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Tumor Biopsy Revenue
3.4 Global Liquid Tumor Biopsy Market Concentration Ratio
3.4.1 Global Liquid Tumor Biopsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Tumor Biopsy Revenue in 2021
3.5 Liquid Tumor Biopsy Key Players Head office and Area Served
3.6 Key Players Liquid Tumor Biopsy Product Solution and Service
3.7 Date of Enter into Liquid Tumor Biopsy Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Liquid Tumor Biopsy Breakdown Data by Type
4.1 Global Liquid Tumor Biopsy Historic Market Size by Type (2017-2022)
4.2 Global Liquid Tumor Biopsy Forecasted Market Size by Type (2023-2028) 5 Liquid Tumor Biopsy Breakdown Data by Application
5.1 Global Liquid Tumor Biopsy Historic Market Size by Application (2017-2022)
5.2 Global Liquid Tumor Biopsy Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Liquid Tumor Biopsy Market Size (2017-2028)
6.2 North America Liquid Tumor Biopsy Market Size by Type
6.2.1 North America Liquid Tumor Biopsy Market Size by Type (2017-2022)
6.2.2 North America Liquid Tumor Biopsy Market Size by Type (2023-2028)
6.2.3 North America Liquid Tumor Biopsy Market Share by Type (2017-2028)
6.3 North America Liquid Tumor Biopsy Market Size by Application
6.3.1 North America Liquid Tumor Biopsy Market Size by Application (2017-2022)
6.3.2 North America Liquid Tumor Biopsy Market Size by Application (2023-2028)
6.3.3 North America Liquid Tumor Biopsy Market Share by Application (2017-2028)
6.4 North America Liquid Tumor Biopsy Market Size by Country
6.4.1 North America Liquid Tumor Biopsy Market Size by Country (2017-2022)
6.4.2 North America Liquid Tumor Biopsy Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada 7 Europe
7.1 Europe Liquid Tumor Biopsy Market Size (2017-2028)
7.2 Europe Liquid Tumor Biopsy Market Size by Type
7.2.1 Europe Liquid Tumor Biopsy Market Size by Type (2017-2022)
7.2.2 Europe Liquid Tumor Biopsy Market Size by Type (2023-2028)
7.2.3 Europe Liquid Tumor Biopsy Market Share by Type (2017-2028)
7.3 Europe Liquid Tumor Biopsy Market Size by Application
7.3.1 Europe Liquid Tumor Biopsy Market Size by Application (2017-2022)
7.3.2 Europe Liquid Tumor Biopsy Market Size by Application (2023-2028)
7.3.3 Europe Liquid Tumor Biopsy Market Share by Application (2017-2028)
7.4 Europe Liquid Tumor Biopsy Market Size by Country
7.4.1 Europe Liquid Tumor Biopsy Market Size by Country (2017-2022)
7.4.2 Europe Liquid Tumor Biopsy Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Liquid Tumor Biopsy Market Size (2017-2028)
8.2 Asia-Pacific Liquid Tumor Biopsy Market Size by Type
8.2.1 Asia-Pacific Liquid Tumor Biopsy Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Liquid Tumor Biopsy Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Liquid Tumor Biopsy Market Share by Type (2017-2028)
8.3 Asia-Pacific Liquid Tumor Biopsy Market Size by Application
8.3.1 Asia-Pacific Liquid Tumor Biopsy Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Liquid Tumor Biopsy Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Liquid Tumor Biopsy Market Share by Application (2017-2028)
8.4 Asia-Pacific Liquid Tumor Biopsy Market Size by Region
8.4.1 Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Liquid Tumor Biopsy Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Liquid Tumor Biopsy Market Size (2017-2028)
9.2 Latin America Liquid Tumor Biopsy Market Size by Type
9.2.1 Latin America Liquid Tumor Biopsy Market Size by Type (2017-2022)
9.2.2 Latin America Liquid Tumor Biopsy Market Size by Type (2023-2028)
9.2.3 Latin America Liquid Tumor Biopsy Market Share by Type (2017-2028)
9.3 Latin America Liquid Tumor Biopsy Market Size by Application
9.3.1 Latin America Liquid Tumor Biopsy Market Size by Application (2017-2022)
9.3.2 Latin America Liquid Tumor Biopsy Market Size by Application (2023-2028)
9.3.3 Latin America Liquid Tumor Biopsy Market Share by Application (2017-2028)
9.4 Latin America Liquid Tumor Biopsy Market Size by Country
9.4.1 Latin America Liquid Tumor Biopsy Market Size by Country (2017-2022)
9.4.2 Latin America Liquid Tumor Biopsy Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Liquid Tumor Biopsy Market Size (2017-2028)
10.2 Middle East & Africa Liquid Tumor Biopsy Market Size by Type
10.2.1 Middle East & Africa Liquid Tumor Biopsy Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Liquid Tumor Biopsy Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Liquid Tumor Biopsy Market Share by Type (2017-2028)
10.3 Middle East & Africa Liquid Tumor Biopsy Market Size by Application
10.3.1 Middle East & Africa Liquid Tumor Biopsy Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Liquid Tumor Biopsy Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Liquid Tumor Biopsy Market Share by Application (2017-2028)
10.4 Middle East & Africa Liquid Tumor Biopsy Market Size by Country
10.4.1 Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Liquid Tumor Biopsy Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Liquid Tumor Biopsy Introduction
11.1.4 Abbott Laboratories Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.1.5 Abbott Laboratories Recent Developments
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Liquid Tumor Biopsy Introduction
11.2.4 Bio-Rad Laboratories Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.2.5 Bio-Rad Laboratories Recent Developments
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Details
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Liquid Tumor Biopsy Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.3.5 F. Hoffmann-La Roche Recent Developments
11.4 Illumina
11.4.1 Illumina Company Details
11.4.2 Illumina Business Overview
11.4.3 Illumina Liquid Tumor Biopsy Introduction
11.4.4 Illumina Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.4.5 Illumina Recent Developments
11.5 QIAGEN N.V.
11.5.1 QIAGEN N.V. Company Details
11.5.2 QIAGEN N.V. Business Overview
11.5.3 QIAGEN N.V. Liquid Tumor Biopsy Introduction
11.5.4 QIAGEN N.V. Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.5.5 QIAGEN N.V. Recent Developments
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Liquid Tumor Biopsy Introduction
11.6.4 Thermo Fisher Scientific Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.6.5 Thermo Fisher Scientific Recent Developments
11.7 Amoy Diagnostics
11.7.1 Amoy Diagnostics Company Details
11.7.2 Amoy Diagnostics Business Overview
11.7.3 Amoy Diagnostics Liquid Tumor Biopsy Introduction
11.7.4 Amoy Diagnostics Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.7.5 Amoy Diagnostics Recent Developments
11.8 HaploX
11.8.1 HaploX Company Details
11.8.2 HaploX Business Overview
11.8.3 HaploX Liquid Tumor Biopsy Introduction
11.8.4 HaploX Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.8.5 HaploX Recent Developments
11.9 Whole Genome Sequencing
11.9.1 Whole Genome Sequencing Company Details
11.9.2 Whole Genome Sequencing Business Overview
11.9.3 Whole Genome Sequencing Liquid Tumor Biopsy Introduction
11.9.4 Whole Genome Sequencing Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.9.5 Whole Genome Sequencing Recent Developments
11.10 Burning Rock Biotech
11.10.1 Burning Rock Biotech Company Details
11.10.2 Burning Rock Biotech Business Overview
11.10.3 Burning Rock Biotech Liquid Tumor Biopsy Introduction
11.10.4 Burning Rock Biotech Revenue in Liquid Tumor Biopsy Business (2017-2022)
11.10.5 Burning Rock Biotech Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
